Table 4 Gender and tooth distribution across treatment groups
From: In vivo and in situ evaluation of innovative approaches in dentin hypersensitivity treatment
| Â | Â | PRG | Embrace | Duraphat | p-value | |||
|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | |||
Gender | Males | 11 | 52.4% | 8 | 38.1% | 8 | 47.1% | 0.639 |
| Â | Females | 10 | 47.6% | 13 | 61.9% | 9 | 52.9% | |
Teeth | Anterior teeth | 16 | 76.2% | 12 | 57.1% | 12 | 57.1% | 0.195 |
| Â | Premolar teeth | 5 | 23.8% | 9 | 42.9% | 9 | 42.9% | Â |